Bioteknisk forskning och utveckling i Stockholm SNI 72101
I bioteknisk forskning och utveckling i Stockholm kommun finns 92 aktiebolag med årsredovisningsdata. Störst är Cellcolabs AB med en omsättning på 44.2 M kr. Största arbetsgivaren är Cellcolabs AB med 68 anställda.
92
aktiebolag
219.7 M
kr i samlad omsättning
239
anställda
-15.5%
median rörelsemarginal
Största bolagen i Stockholm 2026 — efter omsättning, senaste bokslut
| # | Bolag | Omsättning | Rörelseresultat | Marginal | Anställda |
|---|---|---|---|---|---|
| 1 | Cellcolabs AB | 44.2 M | -97.3 M | -202.6% | 68 |
| 2 | QAdvis AB | 38.5 M | 112.8 k | 0.3% | 23 |
| 3 | Xpress Genomics AB | 25.4 M | 11.5 M | 45.2% | 5 |
| 4 | Sweden Medtech4Health AB (svb) | 23.1 M | -1.3 k | -0.0% | 3 |
| 5 | Pharmability AB | 21.6 M | -2.9 M | -13.5% | 1 |
| 6 | IONLACE AB | 14.7 M | -3.8 M | -26.0% | 9 |
| 7 | Smartwise Sweden AB | 10.5 M | -9.0 M | -18.5% | 6 |
| 8 | Salipro Biotech AB | 6.6 M | -5.1 M | -75.1% | 7 |
| 9 | Moligo Technologies AB | 4.7 M | -1.5 M | -12.7% | 4 |
| 10 | AI Biotech Sverige AB | 3.3 M | 809.0 k | 24.3% | 2 |
| 11 | LePeMo Consulting AB | 2.9 M | 1.7 M | 58.6% | 1 |
| 12 | Oxion Biologics AB | 2.9 M | -20.4 M | -144.9% | 3 |
| 13 | Wlness Science Sweden AB | 2.6 M | 15.6 k | 0.6% | 3 |
| 14 | Circio AB | 2.4 M | -22.2 M | -830.1% | 5 |
| 15 | Cloud Gravity AB | 1.8 M | 660.3 k | 37.4% | 1 |
| 16 | ArtSci AB | 1.5 M | 1.4 M | 97.0% | — |
| 17 | Zyli medical consulting AB | 1.4 M | 660.1 k | 46.4% | 1 |
| 18 | Rarity Bioscience AB | 1.4 M | -20.2 M | -814.7% | 16 |
| 19 | Celluxtreme AB | 1.1 M | 233.5 k | 5.2% | 5 |
| 20 | Redutt AB | 1.0 M | 157.6 k | 15.4% | — |
| 21 | MSunds Research Consulting Services AB | 886.4 k | 233.9 k | 26.2% | 1 |
| 22 | ImmCon AB | 816.2 k | 801.1 k | 98.1% | 0 |
| 23 | Fulgurite AB | 782.4 k | -167.5 k | -21.4% | 1 |
| 24 | FREDRIK BUCH KONSULT AKTIEBOLAG | 779.6 k | -195.0 k | -25.0% | 1 |
| 25 | BioFysiologisk Analys Sverige AB | 694.2 k | 12.2 k | 1.8% | — |
| 26 | Ranrike Vetenskap AB | 484.8 k | 476.7 k | 89.1% | — |
| 27 | Medirista Biotechnologies AB | 430.0 k | 343.5 k | 79.9% | — |
| 28 | Binfe AB | 426.0 k | 183.6 k | 43.1% | 1 |
| 29 | ProteomEdge AB | 390.6 k | -6.6 M | -1661.5% | 3 |
| 30 | Westin Noxa-health AB | 351.1 k | 181.1 k | 51.6% | 0 |
| 31 | Anjas Adventures AB | 305.2 k | -79.3 k | -24.0% | 1 |
| 32 | Intelliomic AB | 286.4 k | 58.6 k | 20.4% | 1 |
| 33 | AI Medical Technology AIM AB | 194.5 k | -9.3 M | -97.7% | 7 |
| 34 | Fixell Biotech AB | 185.0 k | -6.4 k | -3.5% | 0 |
| 35 | Biologics Immunology & Analytics - BIA AB | 179.3 k | 148.4 k | 82.8% | 1 |
| 36 | Basic Genomics AB | 154.3 k | -2.6 M | -86.8% | 4 |
| 37 | Recordis AB | 150.0 k | 92.2 k | 61.5% | 1 |
| 38 | Zach Consulting AB | 140.2 k | -45.3 k | -32.3% | — |
| 39 | Spiber Technologies AB | 140.0 k | -18.0 M | -154.1% | 14 |
| 40 | AG Labkonsult AB | 132.9 k | 115.1 k | 86.6% | — |
| 41 | Hikari Bio AB | 96.9 k | -21.8 k | -22.5% | — |
| 42 | AmyloiDia Sweden AB | 83.9 k | 76.3 k | 19.8% | — |
| 43 | CIES Consulting AB | 50.0 k | 6.3 k | 12.5% | 1 |
| 44 | Countagen AB | 37.4 k | -8.3 M | -403.8% | 8 |
| 45 | Dose Medbox International AB | 14.3 k | -2.6 M | -18443.5% | 0 |
| 46 | Nurses Supervision and Research in Stockholm AB | 12.8 k | 547 | 4.3% | — |
| 47 | Isorea AB | 9.1 k | 37.1 k | 1.7% | 2 |
| 48 | Indexit AB | 4.5 k | 4.5 k | 100.0% | — |
| 49 | Desumo Biotechnologies AB | 3.7 k | -15.6 k | -420.4% | — |
| 50 | YOGUT ME AB | 3.0 k | -10.8 k | -356.9% | — |
| 51 | Cell2Bio AB | 6 | -835.0 k | -13917383.3% | 2 |
| 52 | Nordlight Medical AB | 2 | -13.5 k | -674550.0% | — |
| 53 | EVITRAPROTEOMA AB | 0 | 265.5 k | 92.1% | — |
| 54 | Akloma BioScience Aktiebolag | 0 | -1.1 M | — | 0 |
| 55 | Microtus AB | 0 | -42.3 k | — | — |
| 56 | Raise-In AB | 0 | -10.3 k | — | 0 |
| 57 | Novoaim AB | 0 | -20.0 k | — | — |
| 58 | Qgut AB | 0 | -199.4 k | — | 0 |
| 59 | Biomedrex AB | 0 | 1.2 M | 43.9% | 3 |
| 60 | Holy Diver Consulting AB | 0 | -55.7 k | — | 1 |
| 61 | Alertix Veterinary Diagnostics AB | 0 | -1.2 M | -157.4% | 0 |
| 62 | Omnia Biotech AB | 0 | -26.1 k | — | 0 |
| 63 | Tribune Therapeutics AB | 0 | -23.1 M | -14851.2% | 1 |
| 64 | BioDevelopment 101 AB | 0 | -11.0 k | — | — |
| 65 | Oxiant Discovery AB | 0 | 888.0 k | 25.9% | — |
| 66 | Moleculent AB | 0 | -29.1 M | — | 16 |
| 67 | NaturaLens AB | 0 | -16.1 k | -17.5% | — |
| 68 | NYZU AB | 0 | -168.6 k | — | — |
| 69 | Fenode Therapeutics AB | 0 | -1.2 k | — | 0 |
| 70 | Simple Domain AB | 0 | -49.2 k | — | — |
| 71 | Samplimy Medical AB | 0 | 94.3 k | 17.2% | 0 |
| 72 | Line Genomics AB | 0 | -2.8 k | — | — |
| 73 | Agteria Biotech AB | 0 | -7.6 M | -112.8% | 2 |
| 74 | Cutis Skin Health Sweden AB | 0 | -72.8 k | — | — |
| 75 | Caneon AB | 0 | -2.2 M | — | — |
| 76 | AdvantCells Nordic AB | 0 | -411.8 k | -11839.3% | 0 |
| 77 | BIOLYSION AB | 0 | -385.2 k | — | 1 |
| 78 | GenomeVault AB | 0 | -126.2 k | — | 1 |
| 79 | Extendo Medical AB | -1 | -119.3 k | — | 0 |
| 80 | Arandi Development AB | -2 | -22.3 k | — | — |
| 81 | Abioche AB | -2 | -25.0 k | — | 0 |
| 82 | ALPHABETA AKTIEBOLAG | — | -411.9 k | — | — |
| 83 | Philomela AB | — | -28.3 k | — | — |
| 84 | CreMed AB | — | -2.2 M | -23.3% | — |
| 85 | FenoMark Diagnostics AB | — | -1.8 M | -364.8% | 1 |
| 86 | Mitti Lifetek AB | — | -172.5 k | -680.4% | 0 |
| 87 | Glycolink AB | — | -1.5 M | -127.6% | 2 |
| 88 | xseed AB | — | -135.6 k | -451.9% | 1 |
| 89 | NEXUS Epigenomics AB | — | -49.5 k | -2405.0% | — |
| 90 | Ciprocity AB | — | -77.6 k | -1523.8% | — |
| 91 | Berzelii Pharma AB | — | -67.5 k | — | — |
| 92 | Bugsee AB | — | -4.4 k | — | — |
Största arbetsgivare — anställda
| 1 | Cellcolabs AB | 68 |
| 2 | QAdvis AB | 23 |
| 3 | Rarity Bioscience AB | 16 |
| 4 | Moleculent AB | 15 |
| 5 | Spiber Technologies AB | 14 |
| 6 | IONLACE AB | 9 |
| 7 | Countagen AB | 8 |
| 8 | AI Medical Technology AIM AB | 7 |
| 9 | Salipro Biotech AB | 7 |
| 10 | Smartwise Sweden AB | 6 |
Snabbast växande — omsättning, 3 år (CAGR)
| 1 | Moligo Technologies AB | 16611.5% |
| 2 | Cellcolabs AB | 682.5% |
| 3 | Rarity Bioscience AB | 264.8% |
| 4 | AI Biotech Sverige AB | 94.2% |
| 5 | Smartwise Sweden AB | 80.9% |
| 6 | Celluxtreme AB | 49.3% |
| 7 | Sweden Medtech4Health AB (svb) | 39.2% |
| 8 | ArtSci AB | 15.0% |
| 9 | LePeMo Consulting AB | 11.7% |
| 10 | Redutt AB | 6.2% |
Mest lönsamma — rörelsemarginal, min 5 Mkr
| 1 | Xpress Genomics AB | 45.2% |
| 2 | QAdvis AB | 0.3% |
| 3 | Sweden Medtech4Health AB (svb) | -0.0% |
| 4 | Pharmability AB | -13.5% |
| 5 | Smartwise Sweden AB | -18.5% |
| 6 | IONLACE AB | -26.0% |
| 7 | Salipro Biotech AB | -75.1% |
| 8 | Cellcolabs AB | -202.6% |